secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001193125-24-028369
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks appoints Dr. Cesano to board; Dr. Hillan resigns after 7 years
------------------------------------------------------------------------

- Dr. Alessandra Cesano appointed to board effective Feb 8, 2024, as Class I director with term expiring at 2025 AGM.
- Dr. Kenneth Hillan resigned Feb 6, effective Feb 8, not due to disagreement; he served 7 years on the board.
- Cesano receives initial option to purchase 74,000 shares per standard non-employee director compensation plan.
- Cesano appointed to nominating & governance and R&D committees; Derek Miller becomes chair of nominating committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524028369/0001193125-24-028369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312524028369/d642755d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-028369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer